Summary.-The weights of osteosarcomata that arose 22 days after the s.c. injection of cell suspensions (of whole tumours) that had been exposed in vitro to tRNA were significantly different from the weights of those arising from untreated cells. The tRNA was isolated by phenol extraction and DEAE-cellulose chromatography from eviscerated full-term rat embryos, from rat mesenchymal (granulation) tissue and from rat anaplastic osteosarcomata. Tumours developing from osteosarcoma cells treated with either embryonic or normal mesenchymal tRNA were reduced in weight by 76% and 600 respectively. These effects could not be explained as a toxic consequence, because tumour weight was increased by 128% after exposure of cells to osteosarcoma tRNA. In this osteosarcoma model it appears that tumour weights can be influenced in different ways by tRNA from different sources.
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IT IS KNOWN that tumour and other cells can effectively take up transfer ribonucleic acids (tRNA) in vitro, and that an appreciable percentage of this retains its polymeric form for some hours and remains functional, i.e., able to accept amino acids (Herrera, Adamson and Gallo, 1970; Busch et al., 1972; Volkin et al., 1973) .
In view of reports of differences either in the amount of one isoaccepting tRNA species or in the number of isoaccepting species in various tissues during embryogenesis (Taylor et al., 1971 ) and regeneration (Agarwal, Hanoune and WTeinstein, 1970) or oncogenesis (Baliga et al., 1969) , it is conceivable that changes in tRNA may be crucial for maintaining a cell in a particular state of differentiation.
Several workers have reported that the addition to tumour cells of exogenous RNA, extracted from normal tissues, could inhibit their growth (De Carvallo and Rand, 1961; Niu, Cordova and Niu, 1961; Aksenova et al., 1962) . Recent investigations of uptake of RNA have shown that recipient cells preferentially take up tRNA (Volkin et al., 1973) and that the degree of degradation of 4S RNA is less than that of the other types of RNA studied (Okada and Busch, 1972 (Yang, 1971 ; Gonano, Pirro and Silvetti, 1973) . Transfer RNA derived from anaplastic osteosarcomata was used to determine whether or not a " double dose " of the tRNA species present in the tumour cells would enhance growth.
MATERIALS AND METHODS
Sources of tRNA.-Transfer RNA was isolated and purified from rat embryonic tissue, from normal rat mesenchymal tissue and from a rat non-bone-forming osteosarcoma. The full-term embryos were eviscerated to ensure the greatest yield of mesenchymal tRNA. The mesenchymal tissue was obtained from granuloma pouches, produced by a 0-1 ml injection of 1% croton oil suspended in corn oil (Selye, 1953) .
Tumours.-Osteosarcomata were of the 20th to 41st transplant generations of a tumour induced in an inbred DA rat by 32p as previously described (Geddes-Dwyer et al., 1974) . They were non-calcifying, very cellular with a minimum of matrix, and transplanted at 3-4 week intervals depending on experimental requirements.
Preparation of tRNA.-The following precautions were taken to reduce the possibility of degradation of tRNA during preparation. (a) Because ribonuclease has a high affinity for glass (Hummel and Anderson, 1956) with 30 ml of 10-M NaCl, 0-005M EDTA in 0-1 M Tris-chloride buffer at pH 7-5 and 30 ml phenol saturated with this solution. The homogenate was centrifuged for 20 min at 5000g. The aqueous phase was removed with a sterile pipette, mixed with an equal amount of buffersaturated phenol, and re-centrifuged as above. The aqueous layer was carefully pipetted off. Three volumes of 95% ethanol containing 2% potassium acetate were added to it and any DNA present was spooled out as a rapidly forming precipitate. After a minimum of 2 h at -20°C the nucleic acid flocculated in the remaining aqueous layer/ethanol solution.
(ii) DEAE-cellulose chromatography
The tRNA was further purified by ion-exchange chromatography (Holley et al., 1961) . The sample to be chromatographed was dissolved in 0u1 M Tris-buffer and applied to a squat DEAE-cellulose column (8 cm) ) with a diameter of 2 cm. All contaminating polysaccharides and neutral proteins were washed off with 1-5 1 of 0-1 M Tris-buffer at pH 7-5. Stepwise elution was then performed using 0-25 M, 0-6 M, I M and 2 M NaCl in 0-2 M Tris-buffer (pH 7.5). UV analysis was carried out on the eluted samples and fractions containing the tRNA, which elutes at 0-6 M NaCl (Fig. 1 (Hotchkiss, 1975) . The yield of tRNA was approximately 0-5 mg/g of tissue extracted.
Gel electrophoresis of lyophilized fraction.-This was carried out on both 12% and 7% acrylamide/0-35% bisacrylamide at 50 V and 3 mA per gel for 6 h in 0-12 M Tris/0-05 M NaAc/0-003 M EDTA at pH 7-8. E. coli RNAs were used as markers in order to establish the sedimentation velocity of this fraction.
Assay of tRNA amino acid-accepting activity.-Both the preparation of aminoacyl synthetase and the assay were performed according to the methods described by Gallo and Pestka (1970) with the following minor modifications: (i) tRNA was removed from all amino-acyl tRNA synthetase preparations by precipitation with 5% streptomycin sulphate; (ii) endogenous amino acids were removed by Sephadex G25 chromatography; (iii) protein hydrolysate -14C (Amersham) with a specific activity of 57 ,uCi/milli-atom carbon was used as a source of uniformly labelled amino acids in the assay; (iv) the precipitates, after being washed with 5 % trichloracetic acid and dried with an infra-red lamp on the HA Millipore filters were counted in a scintillant cocktail (toluene: PPO: POPOP: 100 ml: 400 mg: 2 mg). Counting on filters was checked by the oxygen flask combustion method (Kalberer and Rutchmann, 1961 ) and comparable results were obtained.
Preparation and treatment of cells.-Cells that were to be exposed to the tRNA were separated enzymatically with pronase (2 mg/ml, Calbiochem) and DNAase (125 ,ug/ml, Sigma-DN25). Between 107 and 108 cells/g of tumour tissue were obtained.
The lyophilized tRNA was dissolved in Eagle's medium and added at a concentration of 500 ,ug/ml (Herrera et al., 1970) to an aliquot of tumour cells (2 x 106 cells/ml) suspended in Eagle's medium without serum and buffered with Hepes. This mixture was left on an orbital shaker at 4°C overnight. Two controls, one containing Eagle's medium and cells only and the other containing cells plus degradation products from RNAase digestion of tRNA, were similarly treated. In the latter control, tRNA (500 ,g/ml) had been incubated with RNAase (Calbiochem-bovine pancreas, 100 [kg/ml) at 370C for 10 min and the resultant breakdown products were then added to the aliquot of tumour cells. Cell numbers or viability did not drop in either the control or ex. perimental aliquots after this 15 h incubation.
The treated and the control cells were spun down, washed and re-counted. Each aliquot was subdivided into 0-5 ml quantities containing 2 x 106 cells for deep s.c. injection into the flank of syngeneic rats of the same sex and weight for the control and experimental series. Between 4 and 8 rats were used in each experimental series. After 22 days all animals were killed and the tumours removed and weighed. Eleven separate experiments, utilizing freshly prepared tRNA in each instance, were carried out.
RESULTS

Purity of tRNA preparation
Any mononucleotides or protein contaminating the tRNA preparation applied to the DEAE-cellulose column were eluted with 0-25 M NaCl in the Tris buffer (indicated by the first peak in Fig. 1 ). The 260/280 ratio (u.v. analysis) of the tRNA fraction eluted with 0-6 M NaCl was always >2. No protein was detected by the Lowry method of estimation. Although there may have been some protein present, it appeared to have had no effect, as was shown by the unaltered behaviour of cells exposed to the RNAase-treated preparation.
Co-electrophoresis of the lyophilized fraction with E. coli RNA markers on the gels showed that the peak obtained coincided with the 4S RNA of E. coli (Fig. 2) . Electrophoresis on 12% acrylamide gels showed that there was no contamination of the fraction with either DNA or high molecular weight RNA. Calculation showed that the tRNA was functional with approximately 80% of the preparation aminoacylated.
Effect of exogenous tRNA on tumour weights
Tumours derived from osteosarcoma cell suspensions exposed to either the embryonic or mesenchymal tissue tRNA weighed less at the end of the 22-day experimental period (76% and 60% respectively) than those derived from control cells. Tumours developing from osteosarcoma cell suspensions exposed to tRNA derived from an osteosarcoma grew much larger (128%) than those from the cells without such treatment. Student's t test of all the data for each treatment showed that the differences between control and experimental were significant (Table) .
Tumours from osteosarcoma cells exposed to tRNA degraded wvith pancreatic RNAase were not significantly different in weight from the weights of tumours from untreated cells.
DISCUSSION
Interpretation of the many biological and biochemical effects ascribed to exogenous RNA (Bhargava and Shanmugan, 1971 ) has been made difficult because total RNA or a mixture of RNAs have (Lanks and Weinstein, 1970; Brenner and Ames, 1972) and specific tRNAs may have regulatory effects, e.g. on cell division (Ortwerth and Liu, 1973) . A simple explanation of the mechanisms by which a non-physiological input of tRNA into tumour cells causes growth alterations could be based on a competitive-inhibition role of de-acylated tRNA (Kyner, Zabos and Levin, 1973 in tumour growth after the treatment with various tRNAs may reflect a modification of protein synthesis and cell phenotype as a consequence of a regulatory action, or as a result of competitive inhibition.
Although the mechanism of action of the exogenous tRNA is a matter for speculation, there is no doubt that, when cell suspensions from our 32P-induced osteosarcomata were exposed to different tRNAs, the weights of the resulting tumours at 22 days were significantly different. 
